4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 625 employees. Its market capitalization is roughly $766 million. In the fiscal year ended 2025-12-31, GYRE reported $117M in revenue and $5M in net income.
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
Interactive charts & full statements → Open the GYRE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $117M | $106M | $114M | $102M | — |
| Gross Profit | $111M | $102M | $109M | $98M | — |
| Operating Income (EBIT) | $12M | $16M | $19M | $9M | — |
| Net Income | $5M | $12M | ($93M) | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $22M | $37M | $31M | $27M | $22M | — |
| Gross Profit | $21M | $36M | $29M | $26M | $21M | — |
| Operating Income (EBIT) | ($7M) | $0M | $7M | $2M | $2M | — |
| Net Income | ($9M) | ($2M) | $4M | $0M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $166M | $125M | $116M | $85M | — |
| Total Liabilities | $24M | $27M | $103M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GYRE viewer.
About TickerBase · Data methodology & sources